| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c35a35cd10cb867ffed513f4eff87950
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-27 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27 |
| filingDate |
1995-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eef0a6f71b43df157f153bfa14c8f2f |
| publicationDate |
1996-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9611704-A1 |
| titleOfInvention |
A pharmaceutical formulation comprising a growth hormone and leucine |
| abstract |
A pharmaceutical formulation comprising a growth hormone and leucine shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved formulation at ambient temperature. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012213846-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013045239-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0133977-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6838075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7098029-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6569406-B2 |
| priorityDate |
1994-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |